One study analyzed nearly 100 CBD products to test the accuracy of advertised cannabinoid content.
A recent study found that a high percentage of various types of hemp-derived cannabidiol (CBD) products contained inaccurate claims on their labels. The 97 products tested in this study consisted of haircare and cosmetic items, food, drinks, and edibles that were purchased in 2020 in Maryland from both retail stores and online. All the products’ labels claimed they contained CBD or specified amounts of CBD that the product contained.
Using gas chromatography-mass spectrometry (GC-MS), the researchers measured the cannabinoid concentration of each product, compared it to the advertised amount, and measured the deviation.
Overall, most of the labels were found to contain inaccurate information regarding CBD content. In particular, 10 products were determined to not contain any CBD.
Some of the other results included (1):
The products tested included ones that stated claims for third-party testing, though the accuracy of CBD content did not differ significantly between products with and without external testing claims.
“Many products made therapeutic claims or used marketing tactics to seemingly convey they were safe/healthy, but only about one-third included disclaimers that these statements had not been evaluated by the FDA,” the researchers also concluded. “These findings highlight the need for proper regulatory oversight of cannabinoid-containing products to ensure quality assurance and deter misleading or unfounded health claims in product marketing.”
Reference